纳微科技连跌4天，中欧基金旗下1只基金位列前十大股东

Company Overview - Suzhou Nanwei Technology Co., Ltd. specializes in the research, large-scale production, sales, and application services of high-performance nano microsphere materials, providing core microsphere materials and related technical solutions for clients in the biomedicine, flat panel display, analytical testing, and in vitro diagnostics sectors [1] Stock Performance - Nanwei Technology has experienced a decline in stock price for four consecutive trading days, with a cumulative drop of -5.85% [1] Fund Involvement - The China Europe Medical Health Mixed A Fund, managed by Guo Lan, has entered the top ten shareholders of Nanwei Technology as a new investor in the first quarter of this year [1] - The fund has reported a year-to-date return of -0.38%, ranking 3365 out of 4503 in its category [1] Fund Manager Profile - Guo Lan, the fund manager of China Europe Medical Health Mixed A, holds a Ph.D. in Biomedical Engineering from Northwestern University in the United States and has extensive experience in research and fund management [3][4]